Yacov Shacham1, Eran Leshem-Rubinow2, Arie Steinvil2, Gad Keren2, Arie Roth2, Yaron Arbel2. 1. Department of Cardiology, Tel-Aviv Sourasky Medical Center Affiliated to the Sackler Faculty of Medicine, Tel-Aviv University, 6 Weizman Street, 64239, Tel Aviv, Israel. kobyshacham@gmail.com. 2. Department of Cardiology, Tel-Aviv Sourasky Medical Center Affiliated to the Sackler Faculty of Medicine, Tel-Aviv University, 6 Weizman Street, 64239, Tel Aviv, Israel.
Abstract
BACKGROUND: Elevated periprocedural high sensitive C-reactive protein (hs-CRP) was shown to be associated with an increased risk for acute kidney injury (AKI) in non-myocardial infarction (MI) patients undergoing percutaneous coronary intervention (PCI), however, no information to date is present regarding its predicting role for AKI in MI patients. We evaluated whether admission serum hs-CRP levels may predict risk of AKI among ST elevation MI (STEMI) patients undergoing primary PCI. METHODS: Five hundred and sixty-two patients that were admitted with STEMI and treated with primary PCI were included in the study. Serum hs-CRP levels were determined from blood samples taken prior to PCI. Patients' medical records were reviewed for occurrence of AKI, in-hospital complications and 30 days mortality. RESULTS: Mean age was 62 ± 16 and 455 (80 %) were males. Patients were divided into two groups, according to their admission hs-CRP values: group 1: hs-CRP ≤9 mg/l (n = 394) and group 2: hs-CRP >9 mg/l (n = 168). Patients with hs-CRP >9 mg/l had significantly higher rate of AKI following PCI (17 vs. 6 %; p < 0.001), more in-hospital complications and higher30 -day mortality rate (11 vs. 1 %; p = 0.02). In a multivariable logistic regression model admission hs-CRP level >9 mg/l was an independent predictor for AKI (OR 2.7, 95 % CI: 1.39-5.29; p = 0.001) and a strong trend for 30 day mortality (OR 4.27, 95 % CI: 0.875-21.10; p = 0.07). CONCLUSION: Admission serum hs-CRP level >9 mg/l is an independent predictor for AKI following primary PCI in STEMI patients.
BACKGROUND: Elevated periprocedural high sensitive C-reactive protein (hs-CRP) was shown to be associated with an increased risk for acute kidney injury (AKI) in non-myocardial infarction (MI) patients undergoing percutaneous coronary intervention (PCI), however, no information to date is present regarding its predicting role for AKI in MI patients. We evaluated whether admission serum hs-CRP levels may predict risk of AKI among ST elevation MI (STEMI) patients undergoing primary PCI. METHODS: Five hundred and sixty-two patients that were admitted with STEMI and treated with primary PCI were included in the study. Serum hs-CRP levels were determined from blood samples taken prior to PCI. Patients' medical records were reviewed for occurrence of AKI, in-hospital complications and 30 days mortality. RESULTS: Mean age was 62 ± 16 and 455 (80 %) were males. Patients were divided into two groups, according to their admission hs-CRP values: group 1: hs-CRP ≤9 mg/l (n = 394) and group 2: hs-CRP >9 mg/l (n = 168). Patients with hs-CRP >9 mg/l had significantly higher rate of AKI following PCI (17 vs. 6 %; p < 0.001), more in-hospital complications and higher30 -day mortality rate (11 vs. 1 %; p = 0.02). In a multivariable logistic regression model admission hs-CRP level >9 mg/l was an independent predictor for AKI (OR 2.7, 95 % CI: 1.39-5.29; p = 0.001) and a strong trend for 30 day mortality (OR 4.27, 95 % CI: 0.875-21.10; p = 0.07). CONCLUSION: Admission serum hs-CRP level >9 mg/l is an independent predictor for AKI following primary PCI in STEMI patients.
Authors: Seung Seok Han; Shin Young Ahn; Jiwon Ryu; Seon Ha Baek; Kwang-il Kim; Ho Jun Chin; Ki Young Na; Dong-Wan Chae; Sejoong Kim Journal: Tohoku J Exp Med Date: 2014-03 Impact factor: 1.848
Authors: Hitinder S Gurm; Simon R Dixon; Dean E Smith; David Share; Thomas Lalonde; Adam Greenbaum; Mauro Moscucci Journal: J Am Coll Cardiol Date: 2011-08-23 Impact factor: 24.094
Authors: Matthew T James; Susan M Samuel; Megan A Manning; Marcello Tonelli; William A Ghali; Peter Faris; Merril L Knudtson; Neesh Pannu; Brenda R Hemmelgarn Journal: Circ Cardiovasc Interv Date: 2013-01-15 Impact factor: 6.546
Authors: Bernhard Kuch; Wolfgang von Scheidt; Birgitt Kling; Margit Heier; Allmut Hoermann; Christa Meisinger Journal: Am J Cardiol Date: 2008-08-15 Impact factor: 2.778
Authors: Cengiz Burak; Muhammed Süleymanoğlu; Mahmut Yesin; Murat Cap; İbrahim Yıldız; İbrahim Rencüzoğulları; Metin Çağdaş; Yavuz Karabağ; Şerif Hamideyin; Doğan İliş; Erkan Baysal Journal: Med Princ Pract Date: 2020-04-28 Impact factor: 1.927
Authors: Giancarlo Marenzi; Nicola Cosentino; Marco Moltrasio; Mara Rubino; Gabriele Crimi; Stefano Buratti; Marco Grazi; Valentina Milazzo; Alberto Somaschini; Rita Camporotondo; Stefano Cornara; Monica De Metrio; Alice Bonomi; Fabrizio Veglia; Gaetano M De Ferrari; Antonio L Bartorelli Journal: J Am Heart Assoc Date: 2016-07-06 Impact factor: 5.501
Authors: Sun-Kyung Park; Min Hur; Eunhee Kim; Won Ho Kim; Jung Bo Park; Youngwon Kim; Ji-Hyuk Yang; Tae-Gook Jun; Chung Su Kim Journal: PLoS One Date: 2016-11-10 Impact factor: 3.240